NANOG as an adverse predictive marker in advanced non-small cell lung cancer treated with platinum-based chemotherapy.

about

Emerging role of lipid metabolism alterations in Cancer stem cells.Prognostic significance of NANOG expression in solid tumors: a meta-analysis

P2860

Q55438519-515FBDAA-1AF8-472D-A9CE-985FF17EA356 Q58761505-5521E2DA-38C1-4772-8D5E-A1E048F09184

P2860

NANOG as an adverse predictive marker in advanced non-small cell lung cancer treated with platinum-based chemotherapy.

Item

http://www.wikidata.org/entity/Q42364472

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

NANOG as an adverse predictive ...... h platinum-based chemotherapy.

@en

NANOG as an adverse predictive ...... h platinum-based chemotherapy.

@nl

type

Item

label

NANOG as an adverse predictive ...... h platinum-based chemotherapy.

@en

NANOG as an adverse predictive ...... h platinum-based chemotherapy.

@nl

prefLabel

NANOG as an adverse predictive ...... h platinum-based chemotherapy.

@en

NANOG as an adverse predictive ...... h platinum-based chemotherapy.

@nl

P1476

NANOG as an adverse predictive ...... th platinum-based chemotherapy

@en

P2093

Boksoon Chang

http://www.w3.org/2001/XMLSchema#string

Chul Hwan Kim

http://www.w3.org/2001/XMLSchema#string

Kwang Ho In

http://www.w3.org/2001/XMLSchema#string

Myung Jae Park

http://www.w3.org/2001/XMLSchema#string

Sue In Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2015

Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.

Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.

Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.

Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells.

The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer.

Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer.

Cisplatin induces stemness in ovarian cancer.

P304

4625-4633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S144895

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Seung Hyeun Lee

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29033581

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

5614794

http://www.w3.org/2001/XMLSchema#string

NANOG as an adverse predictive marker in advanced non-small cell lung cancer treated with platinum-based chemotherapy.

about

P2860

P2860

NANOG as an adverse predictive marker in advanced non-small cell lung cancer treated with platinum-based chemotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932